Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Description

To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer

Conditions

Tumors

Talk to us

Study Overview

On this page

Study Details

Study overview

To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Condition
Tumors
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
  • 2. Age ≥ 18 years
  • 3. Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
  • 4. Ability to understand and willingness to sign written informed consent
  • 1. History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
  • 2. Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
  • 3. Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Shirley Su, MBBS, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2029-12-31